I’d be remiss if I didn’t thank the many readers over the years who pointed out my mistakes and oversights that led to a correction or amplification. Thank you — you performed a public ...
The gross proceeds to IMUNON from the offering are expected to be approximately $7.0 million, before deducting placement agents’ fees and other estimated offering expenses. The offering is expected to ...
Planned SAD and MAD Studies Mark Key Clinical Inflection Point for Intranasal PTSD and Anxiety . SARASOTA, FL, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) ( ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback